Ionis Pharmaceuticals IONS Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's accrued manufacturing costs?
- Ionis Pharmaceuticals (IONS) reported accrued manufacturing costs of $36.05M in Q1 2026.
- How has Ionis Pharmaceuticals's accrued manufacturing costs changed year-over-year?
- Ionis Pharmaceuticals's accrued manufacturing costs increased by 35.7% year-over-year, from $26.58M to $36.05M.
- What is the long-term trend for Ionis Pharmaceuticals's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's accrued manufacturing costs has grown at a 12.1% compound annual growth rate (CAGR), from $65.73M to $116.24M.